De Omega Benefits Interactions
There are 167 drugs known to interact with De Omega Benefits (cholecalciferol / omega-3 polyunsaturated fatty acids), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 11 are major, 155 are moderate, and 1 is minor.
- View all 167 medications that may interact with De Omega Benefits
- View De Omega Benefits alcohol/food interactions (1)
- View De Omega Benefits disease interactions (7)
Most frequently checked interactions
View interaction reports for De Omega Benefits (cholecalciferol / omega-3 polyunsaturated fatty acids) and the medicines listed below.
- Aleve (naproxen)
- Artificial Tears (ocular lubricant ophthalmic)
- Benadryl (diphenhydramine)
- bupropion
- calcium carbonate
- carbamazepine
- cholestyramine
- clindamycin
- Combiflex (acetaminophen / caffeine / phenyltoloxamine / salicylamide)
- CoQ10 (ubiquinone)
- cyclobenzaprine
- diclofenac
- divalproex sodium
- escitalopram
- esomeprazole
- Estrace Vaginal Cream (estradiol topical)
- Excedrin (acetaminophen / aspirin / caffeine)
- finasteride
- Folate Forte (multivitamin)
- gabapentin
- hydroxyzine
- hyoscyamine
- Linzess (linaclotide)
- meclizine
- metronidazole topical
- multivitamin with minerals
- omeprazole
- oxycodone
- Pepcid (famotidine)
- Vitamin D3 (cholecalciferol)
De Omega Benefits alcohol/food interactions
There is 1 alcohol/food interaction with De Omega Benefits (cholecalciferol / omega-3 polyunsaturated fatty acids).
De Omega Benefits disease interactions
There are 7 disease interactions with De Omega Benefits (cholecalciferol / omega-3 polyunsaturated fatty acids) which include:
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- arrhythmias
- liver disease
- hepatobiliary dysfunction
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.